» Authors » Pasquale Stefanizzi

Pasquale Stefanizzi

Explore the profile of Pasquale Stefanizzi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 100
Citations 932
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Simonetti V, Tomietto M, Comparcini D, Pastore F, Stefanizzi P, Tafuri S, et al.
Hum Vaccin Immunother . 2024 Feb; 20(1):2314383. PMID: 38356279
Vaccination is the principal strategy for primary prevention of infection by Human Papilloma Virus (HPV), which causes different pathological conditions, up to cancer, in both males and females. However, to...
12.
Di Lorenzo A, Stefanizzi P, Tafuri S
Front Public Health . 2024 Jan; 11:1323394. PMID: 38249411
Vaccine hesitancy is a multi-faceted phenomenon, deeply rooted in cultural, socioeconomic and personal background. Communication is deemed fundamental in fighting vaccine hesitancy. Medical communication should be accessible, relying both on...
13.
Gianfredi V, Berti A, Stefanizzi P, DAmico M, De Lorenzo V, Moscara L, et al.
Vaccines (Basel) . 2023 Nov; 11(11). PMID: 38006029
The risk of unfavourable outcomes for SARS-CoV-2 infection is significant during pregnancy and breastfeeding. Vaccination is a safe and effective measure to lower this risk. This study aims at reviewing...
14.
De Maria L, Delvecchio G, Sponselli S, Cafaro F, Caputi A, Giannelli G, et al.
J Clin Med . 2023 Nov; 12(21). PMID: 37959268
At the University Hospital of Bari, during the first year after the start of the mandatory vaccination campaign with BNT162b2 mRNA COVID-19 vaccine, the preliminary results of an observational study...
15.
Stefanizzi P, Di Lorenzo A, Martinelli A, Moscara L, Stella P, Ancona D, et al.
Vaccine . 2023 Oct; 41(48):7096-7102. PMID: 37891052
The four-component recombinant-DNA anti-meningococcus B vaccine (4CMenB) has been approved by the European Medicines Agency in 2013. In Italy, 4CMenB is recommended since 2017 for use in infants under one...
16.
Bianchi F, Stefanizzi P, Di Lorenzo A, de Waure C, Boccia S, Daleno A, et al.
Hum Vaccin Immunother . 2023 Oct; 19(3):2265587. PMID: 37849235
Healthcare workers (HCWs) are among the at-risk groups for whom influenza vaccination is strongly recommended. To assess the proportion of Italian HCWs with positive attitudes toward influenza vaccination, we conducted...
17.
Stefanizzi P, Bianchi F, Moscara L, Martinelli A, Di Lorenzo A, Gesualdo L, et al.
Hum Vaccin Immunother . 2023 Oct; 19(3):2266932. PMID: 37842986
Influenza and Coronavirus Disease 2019 (COVID-19) vaccination are recommended in both solid organ transplant (SOT) candidates and recipients. In Puglia, Southern Italy, an active vaccination offer program has been activated...
18.
Gianfredi V, Stefanizzi P, Berti A, DAmico M, De Lorenzo V, Di Lorenzo A, et al.
Vaccines (Basel) . 2023 Aug; 11(8). PMID: 37631857
The anti-SARS-CoV-2 vaccination is recommended for pregnant women due to the high risk of complications. However, pregnancy has been associated with vaccine hesitancy. Our review aims at summarizing the existing...
19.
Leonardelli M, Mele F, Marrone M, Germinario C, Tafuri S, Moscara L, et al.
Vaccines (Basel) . 2023 Jul; 11(7). PMID: 37515007
Vaccination hesitancy is considered by the World Health Organization as a danger to global health. In recent years, vaccine hesitancy rates to COVID-19 have been studied worldwide. In our study,...
20.
Sponselli S, De Maria L, Caputi A, Stefanizzi P, Bianchi F, Delvecchio G, et al.
J Clin Med . 2023 Jun; 12(11). PMID: 37298025
This retrospective observational study describes the results of an ad-hoc designated prevention protocol aimed at containing the spread of the scabies infestation among healthcare workers (HCWs) of a large University...